InfectoGnostics Research Campus Jena / Thuringian Innovation Cluster for Diagnostics and Biotechnology Partner region of the DBT 2026 in Leipzig

Public-private partnership for innovative infection diagnostics and infection research.

Multi-resistant pathogens are on the rise world-wide. InfectoGnostics has therefore set itself the goal of enabling accurate AMR diagnoses before initiating therapy and translating cutting-edge research into actual diagnostic products.

As a public-private partnership, the InfectoGnostics Research Campus Jena is breaking new ground in the diagnosis of infections. More than 30 partners from science, medicine and industry are working together to develop innovative solutions for the rapid and cost-effective on-site diagnosis of infectious diseases. Promising solutions from research are thus brought more quickly into routine diagnostics in the form of market-ready products, and consequently to users and patients. As a Thuringian innovation cluster, InfectoGnostics is deeply rooted in the state’s innovation landscape and is also well connected with other clusters, commercial enterprises, research institutions, clinics and other stakeholders both nationally and internationally.

The InfectoGnostics Research Campus is one of eight projects in the funding initiative "Research Campus - Public-Private Partnership for Innovations" of the Federal Ministry of Research, Technology and Space (BMFTR). The InfectoGnostics Research Campus Jena represents the BioRegion Thuringia.

Further information can be found at: https://www.infectognostics.de

Contact

Contact Person:

Jens Hellwage, PhD
Managing Director
jens.hellwage@infectognostics.de